Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
暂无分享,去创建一个
D. Levy | R. D'Agostino | P. Wilson | J. Cleeman | D. Lloyd‐Jones | M. Larson | A. Beiser | E. Leip | P. Wilson | D. Levy
[1] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[2] Sudha Seshadri,et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.
[3] R. D'Agostino,et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.
[4] P. Greenland,et al. Risk Factors for Coronary Heart Disease in Men 18 to 39 Years of Age , 2001, Annals of Internal Medicine.
[5] A. Dyer,et al. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. , 2000, JAMA.
[6] S. Grundy. Early detection of high cholesterol levels in young adults. , 2000, JAMA.
[7] R B D'Agostino,et al. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. , 2000, Statistics in medicine.
[8] Philip Greenland,et al. Prevention Conference V Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Executive Summary , 2000 .
[9] Philip Greenland,et al. Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations , 1999 .
[10] H. Tunón,et al. Laxatives and the Ice Man , 1999, The Lancet.
[11] Daniel Levy,et al. Lifetime risk of developing coronary heart disease , 1999, The Lancet.
[12] Daniel Levy,et al. Accuracy of Death Certificates for Coding Coronary Heart Disease as the Cause of Death , 1998, Annals of Internal Medicine.
[13] G. Mancia,et al. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.
[14] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[15] S M Grundy,et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.
[16] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.
[17] A. Mushlin,et al. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. American College of Physicians. Part 1. , 1996, Annals of internal medicine.
[18] W. L. Beeson,et al. Effect of risk factor values on lifetime risk of and age at first coronary event. The Adventist Health Study. , 1995, American journal of epidemiology.
[19] D T Lackland,et al. Mortality rates and risk factors for coronary disease in black as compared with white men and women. , 1993, The New England journal of medicine.
[20] Jeffrey J. Gaynor,et al. On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data , 1993 .
[21] K Y Liang,et al. Serum cholesterol in young men and subsequent cardiovascular disease. , 1993, The New England journal of medicine.
[22] Roger A. Renfrew,et al. Lipid Research Clinics Program. , 1984, JAMA.
[23] J. Albers,et al. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.
[24] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.
[25] W. Kannel,et al. AN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY , 1963, Annals of the New York Academy of Sciences.
[26] B. Brodie,et al. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. , 1952, The Journal of biological chemistry.